Bastas takes control of Juno as Arrotex profits go through roof

Dennis Bastas.
New operation DGB Health to control both generic pharmacos in reputed $1 billion deal, according to finance media One of Australia’s richest individuals Dennis Bastas is now in control of both Arrotex and Juno Pharmaceuticals as the result of a $1 billion deal completed in July, according to the Australian Financial Review. Bastas, who regularly

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous AMA calls on Coalition to back 60-day dispensing
Next The pharmacy world is coming to Australia